Place de ta vitamine D, du sevelamer et du cinacalcet dans la prise en charge des patients en insuffisance rénale [Treatment of secondary hyperparathyroidism in renal insufficiency: role of calcitriol, sevelamer and cinacalcet]

Details

Serval ID
serval:BIB_B8FFEE76BE39
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Place de ta vitamine D, du sevelamer et du cinacalcet dans la prise en charge des patients en insuffisance rénale [Treatment of secondary hyperparathyroidism in renal insufficiency: role of calcitriol, sevelamer and cinacalcet]
Journal
Revue Médicale Suisse
Author(s)
Bonny O., Burnier M.
ISSN
1660-9379[print], 1660-9379[linking]
Publication state
Published
Issued date
2008
Volume
4
Number
147
Pages
589-92, 594-5
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review Publication Status: ppublish
Abstract
Along with the decrease in kidney function arises a secondary hyperparathyroidism, which constitutes one of the most important risk factor for mortality in patients suffering from renal insufficiency. Treating secondary hyperparathyroidism is challenging, as most of the parameters of mineral metabolism are interconnected. We review here the pathophysiology and treatment options of this entity.
Keywords
Calcitriol/therapeutic use, Chelating Agents/therapeutic use, Humans, Hyperparathyroidism, Secondary/drug therapy, Hyperparathyroidism, Secondary/etiology, Naphthalenes/therapeutic use, Polyamines/therapeutic use, Renal Insufficiency/complications, Vitamin D Deficiency/drug therapy, Vitamins/therapeutic use
Pubmed
Create date
27/03/2009 12:38
Last modification date
23/11/2020 12:06
Usage data